Multiple Autoimmune Skin Manifestations in a Patient with Crohn's Disease Treated with a Tumor Necrosis Factor-Alpha Blocker.
作者信息
Zattra Edoardo, D'Incà Renata, Bertollo Giuseppe, Tositti Luca, Russo Irene, Alaibac Mauro
机构信息
Division of Dermatology, Department of Medicine, University of Padua, Padova, Italy.
Division of Gastroenterology, Department of Medicine, University of Padua, Padova, Italy.
出版信息
Ann Dermatol. 2015 Oct;27(5):612-3. doi: 10.5021/ad.2015.27.5.612. Epub 2015 Oct 2.
Abstract
摘要
相似文献
1
Multiple Autoimmune Skin Manifestations in a Patient with Crohn's Disease Treated with a Tumor Necrosis Factor-Alpha Blocker.一名接受肿瘤坏死因子-α阻滞剂治疗的克罗恩病患者出现多种自身免疫性皮肤表现。
Ann Dermatol. 2015 Oct;27(5):612-3. doi: 10.5021/ad.2015.27.5.612. Epub 2015 Oct 2.
2
Mutation in TAGAP is protective of anal sepsis in ileocolic Crohn's disease.TAGAP 基因突变可预防回肠结肠型克罗恩病的肛旁脓肿。
Dis Colon Rectum. 2012 Nov;55(11):1145-52. doi: 10.1097/DCR.0b013e3182676931.
3
Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.一名患有难治性瘘管性克罗恩病的患者，使用抗肿瘤坏死因子-α抗体英夫利昔单抗治疗后，自身免疫性血小板减少症获得长期部分缓解。
Digestion. 2008;78(4):195-200. doi: 10.1159/000187637. Epub 2008 Dec 22.
4
Rare paradoxical adverse event in Crohn's disease: a case report.克罗恩病罕见的矛盾性不良事件：一例报告
Ann Transl Med. 2020 Feb;8(4):133. doi: 10.21037/atm.2019.12.122.
5
Features of Patients With Crohn's Disease and Hidradenitis Suppurativa.克罗恩病与化脓性汗腺炎患者的特征。
Clin Gastroenterol Hepatol. 2016 Jan;14(1):71-9. doi: 10.1016/j.cgh.2015.04.180. Epub 2015 May 5.
6
Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases.使用抗肿瘤坏死因子嵌合单克隆抗体cA2治疗直肠切除术后耐药性会阴转移性克罗恩病：两例报告
Dis Colon Rectum. 1998 Jan;41(1):98-102. doi: 10.1007/BF02236903.
7
Crohn's disease and skin.克罗恩病与皮肤。
United European Gastroenterol J. 2016 Apr;4(2):165-71. doi: 10.1177/2050640615597835. Epub 2015 Aug 21.
8
[Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].肿瘤坏死因子-α抑制剂在肛周瘘管型克罗恩病中的疗效
Orv Hetil. 2013 Dec 8;154(49):1943-8. doi: 10.1556/OH.2013.29770.
9
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.CDP571抗体治疗克罗恩病肿瘤坏死因子-α的随机对照试验。
Lancet. 1997 Feb 22;349(9051):521-4. doi: 10.1016/s0140-6736(97)80083-9.
10
The effect of infliximab on extraintestinal manifestations of Crohn's disease.英夫利昔单抗对克罗恩病肠外表现的影响。
Rheumatol Int. 2005 Aug;25(6):406-10. doi: 10.1007/s00296-004-0467-8. Epub 2004 Aug 12.
本文引用的文献
1
New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris.
J Drugs Dermatol. 2013 Feb;12(2):217-9.
2
Treatment of generalized vitiligo with anti-TNF-α Agents.使用抗TNF-α药物治疗泛发性白癜风。
J Drugs Dermatol. 2012 Apr;11(4):534-9.
3
Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors.用肿瘤坏死因子-α抑制剂治疗难治性慢性荨麻疹。
J Am Acad Dermatol. 2011 Jun;64(6):1221-2. doi: 10.1016/j.jaad.2009.10.043.
4
Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
Dermatology. 2008;216(2):185-6. doi: 10.1159/000111523. Epub 2008 Jan 23.
Zotero 插件